Delivery Order SPE2DE24D0021-SPE2D625F3KVD
Award Date 9/15/25
Potential Completion Date 9/22/25
Potential Value $6.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Fisher Scientific Company L.L.C. received a delivery order award on July 31, 2025, from the Department of Defense's Medical Supply Chain for reagent toxicology CEDIA buprenorphine supplies, with a ceiling value of $8,323.12. This fixed-price delivery order with economic price adjustment provisions is structured as a child contract, indicating it derives from a larger parent agreement—specifically Fisher Scientific's Blanket Purchase Agreement with the Department of Veterans Affairs' Veterans...
- Fisher Scientific Company L.L.C. was awarded a $3,444.40 delivery order contract by the Department of Defense's Medical Supply Chain on July 22, 2025, for the procurement of an analytical profile kit for MedToxScan human urine testing. The contract, which is classified as a child award with no set-aside designation, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award represents a continuation of...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $4,962.50 from the Medical Supply Chain, a defense-focused federal agency, for serum toxicology testing reagents and TRIAG materials. The order, issued on August 20, 2025, with an ultimate completion date of September 4, 2025, will be performed in Pittsburgh, Pennsylvania. This delivery order was awarded without a set-aside designation through open competition, reflecting Fisher Scientific's established capability...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,225.00 on June 24, 2025, for Thermo Scientific DRI Fentanyl II drugs to support the Medical Supply Chain, a defense-focused federal agency. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is classified as a child contract and carries a completion date of July 1, 2025. No set-aside designation was used in this procurement, indicating open competition. The supplies...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 31, 2025, for the procurement of reagent toxicology methadone metabolite supplies, valued at $1,177.60, with an ultimate completion date of August 7, 2025. This fixed-price delivery order with economic price adjustment represents a child contract under a larger federal vehicle and will be performed in Pittsburgh, PA. The award was made by the Medical Supply Chain division of the Department of Defense without a set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,022.50 on August 19, 2025, by the Medical Supply Chain division of the Defense Department. The contract, which employs fixed-price pricing with economic price adjustment terms, calls for the delivery of 3AS HCG STAT 10MIU ULTRA 30/pack units to support operations in Pittsburgh, Pennsylvania. The delivery order is expected to conclude by August 22, 2025. This award represents a child contract under a larger vehicle and was...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,299.00 on August 15, 2025, for DCA 2000 Kit Reagent (10 tests per package) to support the Medical Supply Chain, a defense-focused component of the federal government. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award utilized open competition with no set-aside designation, reflecting Fisher Scientific's...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $3,577.80 by the Defense Department's Medical Supply Chain on August 22, 2025, for the delivery of cotinine drug reagent testing solution (100 milliliters). The order is classified as a child contract under a larger vehicle and carries an ultimate completion date of August 29, 2025. No set-aside designation was used in this award, reflecting Fisher Scientific's competitive standing in open federal procurement....
- Fisher Scientific Company L.L.C. was awarded a $3,099.96 fixed-price delivery order with economic price adjustment on August 11, 2025, to supply PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits at 25 per package. The contract, which is a child order under a larger vehicle, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 25, 2025. No set-aside designation was used in this award. The funding source is identified as the Medical Supply Chain within the...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $34,334.30 on August 22, 2025, by the Medical Supply Chain, a defense-focused federal agency. The delivery order, designated as "PRCRPLX MS CYTOKINE + CH 96 TS," procures specialized cytokine and chemistry testing supplies for performance at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of September 2, 2025. This award represents a child contract under a...